SecBot SecBot
Insider Cluster (7 insiders) ·Filed Jun 9, 2026

IPSC

Century Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $2K total
Actionable Insight • Neutral

Insider activity is immaterial and provides no trading signal. Monitor upcoming clinical data readouts or partnership announcements for catalysts. The director grants suggest routine compensation, not a bearish view.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
IPSC ▼ -1.42% at T+60d
NEUTRAL call -1.42% · α vs SPY -8.00% · entry $2.12 → $2.09
Entry = T+0 close
Jun 9, 2026
via day close
T+1d
+5.66%
call +5.66% · α +3.96%
$2.24
settled 5mo ago
T+5d
+2.83%
call +2.83% · α -0.60%
$2.18
settled 4mo ago
T+20d
+8.96%
call +8.96% · α +5.34%
$2.31
settled 4mo ago
T+60d
-1.42%
call -1.42% · α -8.00%
$2.09
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Century Therapeutics (IPSC) sold a combined ~$1,632 in open-market sales on June 8, 2026, while five directors received non-cash stock grants of 74,000 shares each on June 11. The open-market sales are trivial at ~0.0004% of the $404M market cap and likely routine liquidity transactions. The director grants are non-cash awards with no economic signal. The cluster is not informative.

Key Financial Metrics

Direction
selling
Total Value
$1.6K
Insiders
7

Key Facts

  • Two insiders sold open-market shares totaling ~$1,632 on June 8, 2026
  • Five directors received non-cash stock grants of 74,000 shares each on June 11, 2026
  • Total open-market sales represent ~0.0004% of $404M market cap — immaterial
  • No C-suite executives (CEO/CFO) participated in open-market sales
  • Director grants are routine compensation awards with zero cash value

Financial Impact

Open-market sales of ~$1,632 represent 0.0004% of market cap — negligible

dilution

Risk Factors

  • No material insider conviction signal from this cluster
  • Biotech sector risk: clinical trial failures could drive significant downside

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IPSC-1781298515366
19 reports for IPSC
Performance horizon
33% Hit rate @ T+1 1 of 3 directional calls Went positive at some point 1 of 3 best @ T+1▲ +1.53%Aug 12, 2026
Filters
Rows
Reports for IPSC — sortable, filterable
TypeNow
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 4/10
$1.53 $1.48▼ −3.27%▼ −3.94%$1.42 (−6.86%)
Oct 2, 2026
25d ago
Press Release
BULLISH ★ 4/10
$1.53 $1.48▼ −3.27%▼ −3.94%$1.42 (−6.86%)
Sep 22, 2026
5w ago
Institutional Cluster
NEUTRAL ★ 3/10
$1.89 $1.76▼ −6.88%▼ −6.16%$1.42 (−24.60%)
Sep 10, 2026
6w ago
3
NEUTRAL ★ 2/10
$1.94 $2.00▲ +3.09%▲ +3.54%$1.42 (−26.55%)
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 5/10
$1.96 $1.93▼ −1.53%▼ −2.23%$1.42 (−27.30%)
Aug 12, 2026
10w ago
Press Release
BEARISH ★ 5/10
$1.96 $1.93▲ +1.53%▲ +2.23%$1.42 (+27.30%)
Jun 16, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$2.25 $2.29▲ +1.78%▲ +1.00%$1.42 (−36.67%)
Jun 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.18 $2.25▲ +3.21%▲ +4.46%$1.42 (−34.63%)
Jun 9, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.12 $2.24▲ +5.66%▲ +3.96%$1.42 (−32.78%)
Jun 9, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.12 $2.24▲ +5.66%▲ +3.96%$1.42 (−32.78%)
Showing 10 of 19

US Market Status

Market Open — Closes in 1h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026